Quarterly report pursuant to Section 13 or 15(d)
Cover
Document and Entity Information
Financial Statements
Condensed Balance Sheets
Condensed Balance Sheets (Parenthetical)
Condensed Statements of Operations
Condensed Statement of Stockholders' Equity
Condensed Statements of Cash Flows
Notes to Financial Statements
Organization, Description of Business and Liquidity and Capital Resources
Significant Accounting Policies
License, Clinical Trial and Sponsored Research Agreements
Related Party Agreements
Property and Equipment
Commitments and Contingencies
Notes Payable
Leases
Stockholders' Equity
Net Loss per Share
Subsequent Events
Accounting Policies
Significant Accounting Policies (Policies)
Notes Tables
License, Clinical Trial and Sponsored Research Agreements (Tables)
Property and Equipment (Tables)
Notes Payable (Tables)
Leases (Tables)
Stockholders' Equity (Tables)
Net Loss per Share (Tables)
Notes Details
Organization, Description of Business and Liquidity and Capital Resources (Details Textual)
Significant Accounting Policies (Details Textual)
License, Clinical Trial and Sponsored Research Agreements (Details)
License, Clinical Trial and Sponsored Research Agreements (Details Textual)
Related Party Agreements (Details Textual)
Property and Equipment (Details)
Property and Equipment (Details Textual)
Notes Payable (Details)
Notes Payable (Details Textual)
Leases (Details)
Leases (Details 1)
Leases (Details 2)
Leases (Details 3)
Leases (Details Textual)
Stockholders' Equity (Details)
Stockholders' Equity (Details 1)
Stockholders' Equity (Details 2)
Stockholders' Equity (Details 3)
Stockholders' Equity (Details Textual)
Net Loss per Share (Details)
Subsequent Events (Details Textual)
Net Loss per Share (Tables)